Log in

ON STAGE

K-pop boy band ENHYPEN planning Glendale tour stop

Tickets for October show go on sale July 19

K-pop powerhouse ENHYPEN are stopping in Glendale as part of their second world tour.

Their Fate Tour comes to Desert Diamond Arena on Tuesday, Oct. 10. Tickets go on sale on AXS.com at 3 p.m. Wednesday, July 19.

ENHYPEN is the first boyband created by Belift Lab, consisting of members JUNGWON, HEESEUNG, JAY, JAKE, SUNGHOON, SUNOO, and NI-KI. Inspired by the ‘hyphen’ that connects one word to another, ENHYPEN means that seven different boys connect to discover one another and grow together.

You must be a member to read this story.

Join our family of readers starting at $5 for your first month and support local, unbiased journalism.


Already have an account? Log in to continue.

Otherwise, follow the link below to join.

Please log in to continue

Log in
I am anchor
ON STAGE

K-pop boy band ENHYPEN planning Glendale tour stop

Tickets for October show go on sale July 19

Posted

K-pop powerhouse ENHYPEN are stopping in Glendale as part of their second world tour.

Their Fate Tour comes to Desert Diamond Arena on Tuesday, Oct. 10. Tickets go on sale on AXS.com at 3 p.m. Wednesday, July 19.

ENHYPEN is the first boyband created by Belift Lab, consisting of members JUNGWON, HEESEUNG, JAY, JAKE, SUNGHOON, SUNOO, and NI-KI. Inspired by the ‘hyphen’ that connects one word to another, ENHYPEN means that seven different boys connect to discover one another and grow together.

ENHYPEN released their fourth mini album “Dark Blood” this past May. As more than 1.3 million copies were sold within a week of release, the album became the band’s third million-seller album following “Dimension: Dilemma” from 2021.

In September 2022, the band embarked on their first world tour and headlined arenas in 12 cities across the globe. ENHYPEN has performed on shows like “MTV Fresh Out Live” and “The Kelly Clarkson Show.”

ENHYPEN, Desert Diamond Arena, Glendale, Arizona

Share with others


Have an opinion on this story? Click here to send a letter to our editors.

Comments

No comments on this item Please log in to comment by clicking here